APA (7th ed.) Citation

Uchiyama, K., Kamano, D., Nagasaka, T., Hama, E. Y., Shirai, R., Sumura, R., . . . Hayashi, K. (2025). Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]. Elsevier.

Chicago Style (17th ed.) Citation

Uchiyama, Kiyotaka, et al. Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]. Elsevier, 2025.

MLA (9th ed.) Citation

Uchiyama, Kiyotaka, et al. Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]. Elsevier, 2025.